TRU-Cut Biopsy in Tumor cHaracterisation
ConditionTumor
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorGeneral University Hospital, Prague
About this trial
Tru-cut biopsy (TCB) is a minimally invasive method to get an adequate sample from the lesion in order to tailor the appropriate management avoiding unnecessary surgery. The aim of our trial is to evaluate the adequacy, accuracy and safety of the method related to the final histology as reference standard.
Eligibility criteria
Qualifiers
new diagnosis of a presumed gynecologic tumor
suspicious recurrence or progression of a known gynecologic malignancy
pelvic/abdominal spread or recurrence of a non-gynecologic tumor (primary tumor or metastasis)
pelvic/abdominal spread of a tumor of unknown origin 2. Age ≥18 years 3. Eastern Cooperative Oncology Group (ECOG) performance status grade <3 4. Not pregnant 5. Signed informed consent form
Disqualifiers
Considered by the investigator to be unsuitable for any treatment
Early stage disease
Age <18 years
Trial design
Treatments tested in this trial
- tru-cut biopsy
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov